AccuStem Sciences, Inc.
ACUT
$0.5008
-$0.1702-25.37%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -54.11% | -48.47% | -54.74% | -45.08% | -17.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -50.45% | -46.52% | -53.98% | -45.26% | -15.95% |
| Operating Income | 50.45% | 46.52% | 53.98% | 45.26% | 15.95% |
| Income Before Tax | 50.45% | 46.52% | 53.98% | 45.26% | 15.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 50.45% | 46.52% | 53.98% | 45.26% | 15.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.45% | 46.52% | 53.98% | 45.26% | 15.95% |
| EBIT | 50.45% | 46.52% | 53.98% | 45.26% | 15.95% |
| EBITDA | 50.51% | 46.57% | 54.03% | 45.32% | -0.50% |
| EPS Basic | 50.45% | 46.54% | 53.98% | 46.76% | 20.29% |
| Normalized Basic EPS | 50.42% | 46.50% | 53.98% | 46.75% | 20.28% |
| EPS Diluted | 50.45% | 46.54% | 53.98% | 46.76% | 20.29% |
| Normalized Diluted EPS | 50.42% | 46.50% | 53.98% | 46.75% | 20.28% |
| Average Basic Shares Outstanding | -0.01% | 0.01% | 0.03% | 3.02% | 6.29% |
| Average Diluted Shares Outstanding | -0.01% | 0.01% | 0.03% | 3.02% | 6.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
